| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910451789803321 |
|
|
Titolo |
Public health law and ethics [[electronic resource] ] : a reader / / edited by Lawrence O. Gostin |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Berkeley, Calif., : University of California Press |
|
New York, N.Y., : Milbank Memorial Fund, c2010 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-280-59292-3 |
9786613622754 |
0-520-94605-7 |
|
|
|
|
|
|
|
|
Edizione |
[Rev. and updated 2nd ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (596 p.) |
|
|
|
|
|
|
Collana |
|
California/Milbank books on health and the public ; ; 4 |
|
|
|
|
|
|
Altri autori (Persone) |
|
GostinLawrence O (Lawrence Ogalthorpe) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Public health laws - United States |
Public health - Moral and ethical aspects |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Frontmatter -- Contents -- Illustrations -- Tables -- Boxes -- Foreword -- Preface -- Conventions Used in This Book -- Abbreviations -- Introduction. Mapping the Issues -- Part One. Foundations of Public Health Law and Ethics -- Part Two. The Law and the Public's Health -- Part Three. Public Health and Civil Liberties in Conflict -- Part Four.The Future of the Public's Health -- Selected Bibliography -- Table of Cases -- Index -- About the Author |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Now revised and expanded to cover today's most pressing health threats, Public Health Law and Ethics probes the legal and ethical issues at the heart of public health through an incisive selection of government reports, scholarly articles, and relevant court cases. Companion to the internationally acclaimed text Public Health Law: Power, Duty, Restraint, this reader can also be used as a stand-alone resource for students, practitioners, scholars,and teachers. It encompasses global issues that have changed the shape of public health in recent years including anthrax, SARS, pandemic flu, biosecurity, emergency preparedness, and the transition from |
|
|
|
|
|
|
|
|
|
|
|
|
|
infectious to chronic diseases caused by lifestyle changes in eating and physical activity. In addition to covering these new arenas, it includes discussion of classic legal and ethical tensions inherent to public health practice, such as how best to balance the police power of the state with individual autonomy. |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910557304003321 |
|
|
Autore |
Denora Nunzio |
|
|
Titolo |
Paediatric Formulation: Design and Development |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (205 p.) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
The development of paediatric medicines can be challenging since this is a different patient population with specific needs. A medicine designed for use in paediatric patients must consider the following aspects: patient population variability; the need for dose flexibility; route of administration; patient compliance; excipient tolerability. For example, the toxicity of excipients may differ in children compared to adults and children have different taste preferences. Globally, about 75% of drugs do not carry regulatory approval for use in children; worldwide, many medications prescribed for the treatment of paediatric diseases are used off-label, and less than 20% of package inserts have sufficient information for treating children. This book provides an update on both state-of-the-art methodology and operational challenges in paediatric formulation design and development. It aims at re-evaluating what is needed for more progress in the design and development of age-appropriate treatments for paediatric diseases, focusing on: formulation development; drug delivery design; efficacy, |
|
|
|
|
|
|
|
|
|
|
safety, and tolerability of drugs and excipients. |
|
|
|
|
|
| |